Overview

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults

Status:
Unknown status
Trial end date:
2019-02-22
Target enrollment:
Participant gender:
Summary
The purpose of the clinical trail is to evaluate the pharmacokinetics and safety/tolerability after oral administration of CKD-387 and D635 in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical